2020 brought about a lot of growth across the BioHealth Capital Region (BHCR) as dozens of organizations responded with urgency to address the COVID-19 pandemic. With 20% of the world’s vaccine leaders residing in the region, the BHCR has played a critical role in the pandemic response. In Maryland, nearly $8 Billion in federal, private, and foundational funding has been invested in life sciences companies for coronavirus vaccine research and other immunotherapeutic developments.
Image: https://biobuzz.io